Voloridge Investment Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-235,383
| Closed | -$27.5M | – | 1163 |
|
|
2025
Q1 | $27.5M | Buy |
+235,383
| New | +$27.5M | 0.1% | 269 |
|
|
2023
Q1 | – | Sell |
-53,680
| Closed | -$4.14M | – | 1361 |
|
|
2022
Q4 | $4.14M | Sell |
53,680
-160,113
| -75% | -$12.3M | 0.02% | 712 |
|
|
2022
Q3 | $9.54M | Buy |
213,793
+101,384
| +90% | +$4.52M | 0.05% | 457 |
|
|
2022
Q2 | $4.31M | Sell |
112,409
-102,810
| -48% | -$3.94M | 0.02% | 731 |
|
|
2022
Q1 | $8.91M | Buy |
215,219
+28,894
| +16% | +$1.2M | 0.05% | 444 |
|
|
2021
Q4 | $7.04M | Sell |
186,325
-91,315
| -33% | -$3.45M | 0.04% | 581 |
|
|
2021
Q3 | $9.15M | Buy |
+277,640
| New | +$9.15M | 0.06% | 461 |
|
|
2021
Q2 | – | Sell |
-13,020
| Closed | -$737K | – | 1603 |
|
|
2021
Q1 | $737K | Buy |
+13,020
| New | +$737K | 0.01% | 1104 |
|
|
2020
Q2 | – | Sell |
-7,285
| Closed | -$429K | – | 1250 |
|
|
2020
Q1 | $429K | Buy |
+7,285
| New | +$429K | 0.01% | 758 |
|